Dimensional Fund Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-774,922
| Closed | -$4.52K | – | 3533 |
|
|
2022
Q4 | $4.52K | Buy |
774,922
+112,822
| +17% | +$593K | ﹤0.01% | 2489 |
|
|
2022
Q3 | $4.44M | Sell |
662,100
-154,073
| -19% | -$934K | ﹤0.01% | 2470 |
|
|
2022
Q2 | $3.44M | Buy |
816,173
+37,577
| +5% | +$149K | ﹤0.01% | 2570 |
|
|
2022
Q1 | $2.62M | Buy |
778,596
+63,860
| +9% | +$202K | ﹤0.01% | 2753 |
|
|
2021
Q4 | $2.25M | Sell |
714,736
-28,637
| -4% | -$95.3K | ﹤0.01% | 2816 |
|
|
2021
Q3 | $2.43M | Sell |
743,373
-137,492
| -16% | -$482K | ﹤0.01% | 2800 |
|
|
2021
Q2 | $3.72M | Sell |
880,865
-126,630
| -13% | -$536K | ﹤0.01% | 2688 |
|
|
2021
Q1 | $5.03M | Sell |
1,007,495
-71,675
| -7% | -$579K | ﹤0.01% | 2583 |
|
|
2020
Q4 | $13.6M | Sell |
1,079,170
-15,405
| -1% | -$176K | ﹤0.01% | 2157 |
|
|
2020
Q3 | $10.7M | Sell |
1,094,575
-24,615
| -2% | -$243K | ﹤0.01% | 2159 |
|
|
2020
Q2 | $11.1M | Sell |
1,119,190
-5,630
| -0.5% | -$54K | ﹤0.01% | 2152 |
|
|
2020
Q1 | $9.94M | Sell |
1,124,820
-84,181
| -7% | -$830K | 0.01% | 2122 |
|
|
2019
Q4 | $11.2M | Buy |
1,209,001
+17,893
| +2% | +$127K | ﹤0.01% | 2308 |
|
|
2019
Q3 | $7M | Buy |
1,191,108
+8,922
| +0.8% | +$94.7K | ﹤0.01% | 2486 |
|
|
2019
Q2 | $14.2M | Buy |
1,182,186
+42,753
| +4% | +$460K | 0.01% | 2233 |
|
|
2019
Q1 | $13.8M | Buy |
1,139,433
+10,267
| +0.9% | +$151K | 0.01% | 2257 |
|
|
2018
Q4 | $14.2M | Buy |
1,129,166
+59,671
| +6% | +$824K | 0.01% | 2176 |
|
|
2018
Q3 | $15.9M | Buy |
1,069,495
+126,053
| +13% | +$1.98M | 0.01% | 2238 |
|
|
2018
Q2 | $15.9M | Buy |
943,442
+205,796
| +28% | +$4M | 0.01% | 2218 |
|
|
2018
Q1 | $16.9M | Buy |
737,646
+405,592
| +122% | +$9.02M | 0.01% | 2143 |
|
|
2017
Q4 | $8.59M | Buy |
332,054
+63,165
| +23% | +$1.27M | ﹤0.01% | 2434 |
|
|
2017
Q3 | $3.97M | Sell |
268,889
-33,051
| -11% | -$480K | ﹤0.01% | 2673 |
|
|
2017
Q2 | $4.21M | Hold |
301,940
| – | – | ﹤0.01% | 2647 |
|
|
2017
Q1 | $5.15M | Sell |
301,940
-7,421
| -2% | -$89K | ﹤0.01% | 2554 |
|
|
2016
Q4 | $3.18M | Sell |
309,361
-14,363
| -4% | -$131K | ﹤0.01% | 2685 |
|
|
2016
Q3 | $3.27M | Sell |
323,724
-4,743
| -1% | -$51.8K | ﹤0.01% | 2643 |
|
|
2016
Q2 | $3.69M | Buy |
328,467
+10,452
| +3% | +$133K | ﹤0.01% | 2601 |
|
|
2016
Q1 | $4.34M | Buy |
318,015
+93,667
| +42% | +$1.35M | ﹤0.01% | 2541 |
|
|
2015
Q4 | $4.26M | Buy |
224,348
+179,998
| +406% | +$3.91M | ﹤0.01% | 2583 |
|
|
2015
Q3 | $832K | Buy |
+44,350
| New | +$754K | ﹤0.01% | 3027 |
|
Dimensional Fund Advisors's CNCE Position: Q1 2023 in Review
Dimensional Fund Advisors sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 774,922 shares — an estimated $4.52K sold.
Dimensional Fund Advisors first reported a position in CNCE in Q3 2015 and held it in 30 quarters. The position peaked at $16.9M in Q1 2018. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Dimensional Fund Advisors reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Dimensional Fund Advisors sold 774,922 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $4.52K.
- Dimensional Fund Advisors first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 30 quarters.
- Dimensional Fund Advisors's Concert Pharmaceuticals, Inc. position peaked at $16.9M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.